Results 31 to 40 of about 274,173 (312)

Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysis

open access: yesScientific Reports, 2022
This review aimed to examine the relationship between TP53 mutational status, as determined by genomic sequencing, and survival in squamous cell carcinoma of the head and neck.
Shadi Basyuni   +11 more
doaj   +1 more source

Cancer genomics [PDF]

open access: yesCancer Cell, 2002
The draft human genome sequence and the dissemination of high throughput technology provides opportunities for systematic analysis of cancer cells. Genome-wide mutation screens, high resolution analysis of chromosomal abberations and expression profiling all give comprehensive views of genetic alterations in cancer cells.
openaire   +2 more sources

Contextualization of drug-mediator relations using evidence networks

open access: yesBMC Bioinformatics, 2017
Background Genomic analysis of drug response can provide unique insights into therapies that can be used to match the “right drug to the right patient.” However, the process of discovering such therapeutic insights using genomic data is not ...
Hai Joey Tran   +3 more
doaj   +1 more source

Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort

open access: yesNature Communications, 2023
Renal cell carcinoma (RCC) comprises several histological types characterised by different genomic and epigenomic aberrations; however, the molecular pathogenesis of each type still requires further exploration.
Akihiko Fukagawa   +10 more
doaj   +1 more source

Lung Cancer Genomics [PDF]

open access: yesActa Medica Academica, 2019
<p>The landscape of lung cancer treatment is rapidly evolving with the use of genomic testing which helps identify specific mutations or resistance mutations for these heterogenous tumors. Advanced lung cancer has a very poor prognosis but identifying other treatment options based on genomic profiling of the tumor can lead to improved outcomes ...
openaire   +2 more sources

Genomics of Prostate Cancer: Clinical Utility and Challenges

open access: yesActa Clinica Croatica, 2022
The studying of prostate cancer genomics is important for understanding prostate cancer biology, it can provide clinically relevant stratification into subtypes, the development of new prognostic and predictive markers in the context of precision ...
Ivan Šamija, Ana Fröbe
doaj   +1 more source

Integrated genetic and epigenetic analysis of myxofibrosarcoma

open access: yesNature Communications, 2018
Myxofibrosarcoma occurs in adults and is associated with high local relapse. Here, based on exome/transcriptome sequencing and DNA methylation analysis, the authors identify driver genes and methylation clusters associated with unique combinations of ...
Koichi Ogura   +14 more
doaj   +1 more source

Authorship Patterns in Cancer Genomics Publications Across Africa

open access: yesJCO Global Oncology, 2021
PURPOSEAuthorship is a proxy indicator of research capacity. Understanding the research capacity is imperative for developing population-specific cancer control strategies.
Solomon O. Rotimi   +2 more
doaj   +1 more source

Prostate cancer biology & genomics

open access: yesTranslational Andrology and Urology, 2020
Prostate Cancer is now the second biggest cause of cancer mortality in the UK. Media coverage has been rising, with some attributing to a rise in the cases diagnosed and treated in the NHS down to the "Fry and Turnbull effect". Our understanding of prostate cancer has increased tremendously in the past decades, with advances in molecular biology and ...
Whitaker, Hayley   +3 more
openaire   +3 more sources

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

open access: yesBMC Medical Genomics, 2018
Background Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. Results We created
Adnan Ahmad Ansari   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy